课题基金 / 基金详情

RALOXIFENE HCL AND PLACEBO IN PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSALS

RALOXIFENE HCL AND PLACEBO IN PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSALS
雷洛昔芬盐酸盐和安慰剂预防绝经后骨质疏松症
批准号：
6290971
负责人：
C. CONRAD JOHNSTON
金额：
$1.7万
依托单位：
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
依托单位国家：
美国
项目类别：
财政年份：
1998
资助国家：
美国
项目状态：
已结题
起止时间：
1998-12-01 至 1999-11-30
来源：
https://reporter.nih.gov/project-details/6290971
关键词：
chemoprevention clinical research drug screening /evaluation estrogen inhibitor female human subject human therapy evaluation osteoporosis placebos postmenopause skeletal disorder chemotherapy women's health

项目摘要

项目成果

C. CONRAD JOHNSTON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
A multi-center, double-blind, placebo controlled study studying over 500 subjects at 8 study sites. Subjects will be randomly assigned to 4 parallel therapy groups. The objectives of this phase III trial are to establish the effect of long-term Raloxifene therapy, compared with placebo in healthy subjects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ROLE OF SEX STEROIDS IN AGE-RELATED BONE LOSS
RALOXIFENE HCL AND PLACEBO IN PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSALS
DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMIZED STUDY ON EFFICACY OF IBANDRONATE
RALOXIFENE HCL AND PLACEBO IN PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSALS
海外基金